Autologous Peripheral Blood Stem Cell Therapy for Chronic Achilles Tendinopathy: Report of Three Cases
https://doi.org/10.5704/MOJ.2207.022
- Author:
Saw KY
1
;
Low SF
2
;
Ramlan A
3
;
Dawam A
3
;
Saw YC
3
;
Jee CSY
3
Author Information
1. Department of Orthopaedic Surgery, Kuala Lumpur Sports Medicine Centre, Kuala Lumpur, Malaysia
2. Department of Radiology, Kuala Lumpur Sports Medicine Centre, Kuala Lumpur, Malaysia
3. Stem Cells Research and Development, Kuala Lumpur Sports Medicine Centre, Kuala Lumpur, Malaysia
- Publication Type:Journal Article
- Keywords:
chronic Achilles tendinopathy, tendinitis, peripheral blood stem cells, VISA-A scores
- From:Malaysian Orthopaedic Journal
2022;16(No.2):150-154
- CountryMalaysia
- Language:English
-
Abstract:
The treatment of chronic Achilles tendinopathy (CAT)
remains challenging. We report three cases of CAT treated
with autologous peripheral blood stem cells (PBSCs),
following principles developed for chondrogenesis of the
knee joint. Outcome measurement with a minimum of one
and a half years follow-up showed significant improvement
of Victorian Institute of Sport Assessment-Achilles
questionnaire (VISA-A) scores, with reduction of tendon
thickness and inflammation on MRI scan.
- Full text:16.2022my1264.pdf
